Yiyao Yang , Yuxin Guo , Zhaoliang Wang , Yifan Weng , Tingting Hao , Qingqing Zhang , Shuihua Wang , Zhiyong Guo
{"title":"基于深度学习的形态学分析评估单个肿瘤细胞EMT状态和药物敏感性。","authors":"Yiyao Yang , Yuxin Guo , Zhaoliang Wang , Yifan Weng , Tingting Hao , Qingqing Zhang , Shuihua Wang , Zhiyong Guo","doi":"10.1016/j.bios.2025.118051","DOIUrl":null,"url":null,"abstract":"<div><div>Metastasis driven by the epithelial-mesenchymal transition (EMT) in circulating tumor cells (CTCs) is a major challenge in cancer treatment. Current EMT assessment methods rely on invasive detection of protein or genetic markers, lack single-cell resolution, and fail to provide real-time dynamic insights, especially for rare CTCs. Here, we developed a convolutional neural network (CNN)-based deep learning model that quantifies EMT states in single or scarce CTCs through non-invasive, label-free morphological profiling. First, TGF-β-stimulated EMT induction in MCF-7 cells was monitored through quantitative assessment of EMT-related protein expression, identifying key transitional timepoints. Then, five distinct morphological states representing EMT progression were selected via combined morphological observation. Finally, cellular images from these states were processed by the developed convolutional neural network (CNN) model, which performs label-free morphological profiling at single-cell resolution. This approach enables real-time, individualized evaluation of metastatic potential, advancing precision diagnostics and therapeutic strategies for cancer management.</div></div>","PeriodicalId":259,"journal":{"name":"Biosensors and Bioelectronics","volume":"291 ","pages":"Article 118051"},"PeriodicalIF":10.5000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Deep learning-driven morphological analysis for assessing EMT state and drug sensitivity of single tumor cell\",\"authors\":\"Yiyao Yang , Yuxin Guo , Zhaoliang Wang , Yifan Weng , Tingting Hao , Qingqing Zhang , Shuihua Wang , Zhiyong Guo\",\"doi\":\"10.1016/j.bios.2025.118051\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Metastasis driven by the epithelial-mesenchymal transition (EMT) in circulating tumor cells (CTCs) is a major challenge in cancer treatment. Current EMT assessment methods rely on invasive detection of protein or genetic markers, lack single-cell resolution, and fail to provide real-time dynamic insights, especially for rare CTCs. Here, we developed a convolutional neural network (CNN)-based deep learning model that quantifies EMT states in single or scarce CTCs through non-invasive, label-free morphological profiling. First, TGF-β-stimulated EMT induction in MCF-7 cells was monitored through quantitative assessment of EMT-related protein expression, identifying key transitional timepoints. Then, five distinct morphological states representing EMT progression were selected via combined morphological observation. Finally, cellular images from these states were processed by the developed convolutional neural network (CNN) model, which performs label-free morphological profiling at single-cell resolution. This approach enables real-time, individualized evaluation of metastatic potential, advancing precision diagnostics and therapeutic strategies for cancer management.</div></div>\",\"PeriodicalId\":259,\"journal\":{\"name\":\"Biosensors and Bioelectronics\",\"volume\":\"291 \",\"pages\":\"Article 118051\"},\"PeriodicalIF\":10.5000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biosensors and Bioelectronics\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0956566325009273\",\"RegionNum\":1,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOPHYSICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosensors and Bioelectronics","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0956566325009273","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
Deep learning-driven morphological analysis for assessing EMT state and drug sensitivity of single tumor cell
Metastasis driven by the epithelial-mesenchymal transition (EMT) in circulating tumor cells (CTCs) is a major challenge in cancer treatment. Current EMT assessment methods rely on invasive detection of protein or genetic markers, lack single-cell resolution, and fail to provide real-time dynamic insights, especially for rare CTCs. Here, we developed a convolutional neural network (CNN)-based deep learning model that quantifies EMT states in single or scarce CTCs through non-invasive, label-free morphological profiling. First, TGF-β-stimulated EMT induction in MCF-7 cells was monitored through quantitative assessment of EMT-related protein expression, identifying key transitional timepoints. Then, five distinct morphological states representing EMT progression were selected via combined morphological observation. Finally, cellular images from these states were processed by the developed convolutional neural network (CNN) model, which performs label-free morphological profiling at single-cell resolution. This approach enables real-time, individualized evaluation of metastatic potential, advancing precision diagnostics and therapeutic strategies for cancer management.
期刊介绍:
Biosensors & Bioelectronics, along with its open access companion journal Biosensors & Bioelectronics: X, is the leading international publication in the field of biosensors and bioelectronics. It covers research, design, development, and application of biosensors, which are analytical devices incorporating biological materials with physicochemical transducers. These devices, including sensors, DNA chips, electronic noses, and lab-on-a-chip, produce digital signals proportional to specific analytes. Examples include immunosensors and enzyme-based biosensors, applied in various fields such as medicine, environmental monitoring, and food industry. The journal also focuses on molecular and supramolecular structures for enhancing device performance.